Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy.
Tappero S, Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Garcia CC, Piccinelli M, Tian Z, Parodi S, Montorsi F, Chun FKH, Graefen M, Antonelli A, Saad F, Shariat SF, De Cobelli O, Suardi NR, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: borghesi m. Can Urol Assoc J. 2023 Mar;17(3):E50-E56. doi: 10.5489/cuaj.8056. Can Urol Assoc J. 2023. PMID: 36473471 Free PMC article.
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation.
Mantica G, Suardi N, Smelzo S, Esperto F, Chierigo F, Tappero S, Borghesi M, La Rocca R, Oderda M, Ennas M, Stabile A, De Cobelli F, Napolitano L, Papalia R, Gontero P, Introini C, Briganti A, Scarpa RM, Mirone V, Montorsi F, Gaboardi F, Terrone C, Cardone G. Mantica G, et al. Among authors: borghesi m. Diagnostics (Basel). 2022 Nov 1;12(11):2656. doi: 10.3390/diagnostics12112656. Diagnostics (Basel). 2022. PMID: 36359499 Free PMC article.
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer.
Flammia RS, Chierigo F, Würnschimmel C, Wenzel M, Horlemann B, Tian Z, Borghesi M, Leonardo C, Tilki D, Shariat SF, Anceschi U, Chun FKH, Terrone C, Saad F, Gallucci M, Karakiewicz PI. Flammia RS, et al. Among authors: borghesi m. Cent European J Urol. 2022;75(3):240-247. doi: 10.5173/ceju.2022.0053. Epub 2022 Jul 18. Cent European J Urol. 2022. PMID: 36381153 Free PMC article.
Oligometastatic Prostate Cancer Treated with Metastasis-Directed Therapy Guided by Positron Emission Tomography: Does the Tracer Matter?
Lanfranchi F, Belgioia L, Marcenaro M, Zanardi E, Timon G, Riondato M, Giasotto V, Zawaideh JP, Tomasello L, Mantica G, Piol N, Borghesi M, Traverso P, Satragno C, Panarello D, Scaffidi C, Romagnoli A, Rebuzzi SE, Coco A, Spina B, Morbelli S, Sambuceti G, Terrone C, Barra S, Fornarini G, Bauckneht M. Lanfranchi F, et al. Among authors: borghesi m. Cancers (Basel). 2023 Jan 3;15(1):323. doi: 10.3390/cancers15010323. Cancers (Basel). 2023. PMID: 36612319 Free PMC article.
Efficacy of chemotherapy on overall survival in metastatic sarcomatoid bladder cancer patients.
Tappero S, Sorce G, Panunzio A, Hohenhorst L, Garcia CC, Piccinelli ML, Tian Z, Parodi S, Chun FKH, Graefen M, Antonelli A, De Cobelli O, Saad F, Shariat SF, Montorsi F, Suardi NR, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: borghesi m. Cent European J Urol. 2022;75(4):352-356. doi: 10.5173/ceju.2022.142. Epub 2022 Nov 25. Cent European J Urol. 2022. PMID: 36794025 Free PMC article.
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.
Tappero S, Barletta F, Piccinelli ML, Cano Garcia C, Incesu RB, Morra S, Scheipner L, Tian Z, Parodi S, Dell'Oglio P, Briganti A, de Cobelli O, Chun FKH, Graefen M, Mirone V, Ahyai S, Saad F, Shariat SF, Suardi N, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: borghesi m. Urol Oncol. 2023 Jul;41(7):326.e9-326.e16. doi: 10.1016/j.urolonc.2023.01.015. Epub 2023 Mar 5. Urol Oncol. 2023. PMID: 36882338
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm.
Tappero S, Barletta F, Piccinelli ML, Cano Garcia C, Incesu RB, Morra S, Scheipner L, Tian Z, Parodi S, Dell'Oglio P, Palumbo C, Briganti A, De Cobelli O, Chun FKH, Graefen M, Longo N, Ahyai S, Saad F, Shariat SF, Suardi N, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: borghesi m. Eur Urol Focus. 2023 Sep;9(5):742-750. doi: 10.1016/j.euf.2023.02.010. Epub 2023 Mar 9. Eur Urol Focus. 2023. PMID: 36906483
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapy.
Chierigo F, Flammia RS, Sorce G, Hoeh B, Hohenhorst L, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Montorsi F, Chun FKH, Shariat SF, Guano G, Mantica G, Borghesi M, Suardi N, Terrone C, Karakiewicz PI. Chierigo F, et al. Among authors: borghesi m. Prostate. 2023 May;83(7):695-700. doi: 10.1002/pros.24505. Epub 2023 Mar 15. Prostate. 2023. PMID: 36919872
306 results